Overcoming barriers to success with deep industry expertise
CGI works with pharma, biotech and medical device companies from early stage development, to data capture, to regulatory submission and even late stage development. We partner with them to minimise regulatory and competitive impacts and maximise revenue potential.
London, United Kingdom,
23 November 2020 -
The relationship will see CGI combine its multi-industry and advisory expertise with Wordnerds’ unique software platform to create a new offering.
biotech/pharmaceutical projects completed for 50 clients
Millions
of Danes benefit from a CGI-developed system for pathology
7/10
of the top 10 global pharmaceutical companies are CGI clients
Innovative End To End Services
CGI expertise and services help life sciences organisations increase speed, efficiency and innovation, while keeping pace with compliance demands. Key capabilities include:
Commercial launch and operations to simplify planning and execution and improve launch efficiency
Clinical services to reduce the duration of drug development timelines
Regulatory compliance to help clients continuously monitor clinical drug safety data across the entire product life cycle
Manufacturing innovation to achieve end-to-end supply chain optimisation, manufacturing execution excellence, transport management and ERP, including Industry 4.0
Outsourcing to improve the management and operation of company-wide infrastructures, application suites and business processes
Intelligent automation to increase efficiency of operations by combining advanced analytics with IoT and AI for predictive maintenance.
CGI
Life
Sciences
expert
Balaji
Kuppuswamy
explores
the
questions
of
whether
it
is
the
role
of
the
pharmaceutical
industry
to
engage
with
patients,
and
how
that
relationship
is
and
should
...
As
the
COVID-19
pandemic
rapidly
spread
across
the
globe
in
the
early
months
of
2020,
the
Montreal
Heart
Institute
(MHI)
responded
by
launching
a
major
clinical
study
to
test
a
...
Annually,
CGI
leaders
around
the
world
meet
face-to-face
with
business
and
IT
executives
to
gather
their
perspectives
on
the
trends
affecting
their
enterprises,
including
business
and
IT
priorities,
IT
spending,
...
Before
COVID-19,
5G
was
a
priority
not
only
for
most
mobile
network
operators
but
also
for
government
and
industry.
Now,
the
pandemic
will
inevitably
impact
5G
deployment
plans
and
present
...
March
23,
2020
MONTREAL
--
The
Montreal
Heart
Institute
announces
that
its
Research
Center
is
launching
today
a
COVID-19
clinical
study
in
Canada
to
determine
whether
short-term
...